Lectin-mediated drug delivery in the oral cavity

被引:49
|
作者
Smart, JD [1 ]
机构
[1] Univ Portsmouth, Sch Pharm & Biomed Sci, Biopharmaceut & Drug Delivery Grp, Portsmouth PO1 2DT, Hants, England
关键词
oral cavity; lectin; drug delivery;
D O I
10.1016/j.addr.2003.10.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The delivery of therapeutic agents to, or via, the oral cavity is limited by the efficient removal mechanisms that exist in this area. Lectins are proteins or glycoproteins that bind to specific sugar residues, and can, therefore, interact with the glycoconjugates present on cell surfaces or salivary mucins. Endogenous lectins could also be used as points of attachment for carbohydrate-containing delivery systems. This review considers the possibility of using lectins as targeting agents within the oral cavity and reports on some of the limited number of studies completed to date. As lectins are multifunctional molecules, the possibility of using them as both targeting and therapeutic agents is considered. Lectin-containing delivery systems are a potential innovation for targeted and prolonged therapy within the oral cavity, but considerations such as toxicity and cost will need to be addressed before their routine use becomes a reality. (C) 2003 Elsevier B.V All rights reserved.
引用
收藏
页码:481 / 489
页数:9
相关论文
共 50 条
  • [1] Lectin-mediated drug delivery: fundamentals and perspectives
    Gabor, F
    Wirth, M
    [J]. STP PHARMA SCIENCES, 2003, 13 (01): : 3 - 16
  • [2] Peroral lectin-mediated drug delivery - meeting a challenge?
    Gabor, F
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 23 : S14 - S15
  • [3] Lectin-mediated drug delivery: The second generation of bioadhesives
    Lehr, CM
    [J]. JOURNAL OF CONTROLLED RELEASE, 2000, 65 (1-2) : 19 - 29
  • [4] LECTIN-MEDIATED DRUG DELIVERY FOR INTRAVESICAL TREATMENT OF BLADDER CANCER
    Polster-Wildhofen, S.
    Neutsch, L.
    Wirth, M.
    Gabor, F.
    Zechner, O.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 633 - 633
  • [5] The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery
    Gabor, F
    Bogner, E
    Weissenboeck, A
    Wirth, M
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (04) : 459 - 480
  • [6] Lectin-mediated mucosal delivery of drugs and microparticles
    Clark, MA
    Hirst, BH
    Jepson, MA
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2000, 43 (2-3) : 207 - 223
  • [7] Lectin-mediated drug delivery: influence of mucin on cytoadhesion of plant lectins in vitro
    Wirth, M
    Gerhardt, K
    Warm, C
    Gabor, F
    [J]. JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) : 183 - 191
  • [8] SOLUBLE POLYMERS FOR LECTIN-MEDIATED DRUG TARGETING
    SEYMOUR, LW
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1994, 14 (01) : 89 - 111
  • [9] Lectin-mediated drug targeting: history and applications
    Bies, C
    Lehr, CM
    Woodley, JF
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (04) : 425 - 435
  • [10] Lectin-mediated bioadhesion: wheat germ agglutinin and Solanum tuberosum lectin as targeting moieties in particulate drug delivery systems
    Gabor, F
    Wirth, M
    [J]. EUROPEAN JOURNAL OF CELL BIOLOGY, 1997, 74 : 35 - 35